Hitachi Global Life Solutions (CGT)

Yokohama, Japan
Hybrid — also manufactures internal programs
Cell Therapy CAR-T
Program data pending ClinicalTrials.gov matching · Last scored 2026-04-29
63.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: Hitachi Global Life Solutions (CGT)

Signal Score
63.0/100 (as of 2026-04-29)
Quality Compliance
Assessment pending
Headquarters
Yokohama, Japan
Modalities
Cell Therapy, CAR-T
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Hitachi Global Life Solutions (CGT)

Hybrid developer + CDMO.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesCell Therapy, CAR-T
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 68.0
Parent company: Hitachi
Financial assessment: 68.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: Hitachi
Financial assessment: 68.0/100
Capacity 58.0
1 manufacturing site: Yokohama, JP
Modalities: Cell Therapy, CAR-T
Capacity assessment: 58.0/100
Sites: Yokohama, JP
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
1 manufacturing site: Yokohama, JP
Modalities: Cell Therapy, CAR-T
Capacity assessment: 58.0/100

Frequently Asked Questions About Hitachi Global Life Solutions (CGT)

What is Hitachi Global Life Solutions (CGT)'s CDMO Signal Score?
Hitachi Global Life Solutions (CGT) has a Signal Score of 63/100, based on quality, operations, financial stability, and capacity data.
Evaluating Hitachi Global Life Solutions (CGT) for a manufacturing program?
Use the free AI matchmaker to compare Hitachi Global Life Solutions (CGT) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Cell Therapy CDMOs → CAR-T CDMOs →

Similar CDMOs

Minaris Advanced Therapies
Philadelphia, PA · Allendale, NJ · Munich, DE · Yokohama, JP
Signal Score: 83.5
CAR-T, Cell Therapy
Minaris (WuXi Advanced Therapies)
Philadelphia, PA / Yokohama, Japan
Signal Score: 60.5
CAR-T, Cell Therapy
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 91.7
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
Bristol Myers Squibb (CGT Mfg)
Bothell, WA · Warren, NJ
Signal Score: 90.8
CAR-T, Cell Therapy
City of Hope (T Cell Manufacturing)
Duarte, CA
Signal Score: 83.8
CAR-T, Cell Therapy